Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

All the Latest Game Footage and Images from Night Tail There are monsters in the world that devours human memory and spirit, called dream monster. The protagonist, Yoru, has the power to fight against ...

A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...